Two researchers from the Icahn School of Medicine at Mount Sinai recently published their critical evaluation of a new brain ...

Anyone with any experience as an investor knows that while penny stocks can produce strong returns, they’re also risky. You ...

US poised to approve KarXT as new antipsychotic treatment for disorder, which could offer reduced side-effects ...

Lead program TG4050 (individualized immunotherapy): – First signs of clinical benefit in adjuvant head and neck ... 2024 compared to €4.8 million for the same period in 2023. The research tax credit ...

Clinical research will offer insight for specific targeting of active pharmaceutical ingredients (API) that will further support Phase 1 Human ...

Researchers from Deakin University reveal how yoyo dieting disrupts gut health, leading to weight regain and obesity-related ...

Despite this, there is a paucity of research examining the impact of these ... multi-phase explanatory study (REB 2023-8964) ...

The latest study should be a comfort for caffeine drinkers, but isn't necessarily a sign to start a new habit.

Mahableshwarkar M.D., DLFAPA, Senior Vice President, Clinical Development ... decades of pharmaceutical industry experience in new drug development across all phases of research (pre-IND to ...

According to new research, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) -- including both accelerated or myeloid blast phases of the ...

According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...